Real-World Outcomes of Allogeneic Immunosafe Plasma Rich in Growth Factors Eye Drops for Refractory Ocular Surface Diseases: A Prospective Observational Study

Real-World Outcomes of Allogeneic Immunosafe Plasma Rich in Growth Factors Eye Drops for Refractory Ocular Surface Diseases: A Prospective Observational Study

Abstract Introduction Immunosafe plasma rich in growth factors eye drops (is-ePRGF) have shown anti-inflammatory and regenerative effects on ocular surface diseases (OSD). However, medical or technical issues may preclude some patients from undergoing autologous blood extraction. We aimed to evaluat...

Full description

Saved in:
Bibliographic Details
Main Authors: Rosa Alvarado-Villacorta, Jesús Merayo-Lloves, Ronald M. Sánchez-Ávila, Belén Alfonso-Bartolozzi, Carlos Lisa, Luis Fernández-Vega-Cueto, José F. Alfonso, Eduardo Anitua
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-07-01
Series:Ophthalmology and Therapy
Subjects:
Allogeneic blood-based eye drops
Dry eye disease
Hemoderivatives
Ocular surface disease
Plasma rich in growth factors
PRGF
Online Access:https://doi.org/10.1007/s40123-025-01211-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40123-025-01211-1

Similar Items